Product Information

CLINDAMYCIN PHOSPHATE 1% FOAM is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $1.7318 per GM under NDC 45802066033. Its NADAC has been published 434 times since Nov 28, 2013.

FDA first approved this application on Mar 31, 2010. Its Orange Book therapeutic-equivalence code is AT.

CLINDAMYCIN PHOSPHATE 1% FOAM

clindamycin phosphate
$1.7318per GM

Strength

10 mg/g

NDC

45802066033

Classification

Generic

Dosage Form

AEROSOL, FOAM

Route

TOPICAL

Effective Date

11/18/2026

Active Ingredients

CLINDAMYCIN PHOSPHATE

Approval Type

Generic (ANDA)

FDA Application

ANDA090785

FDA Approved

3/31/2010

TE Code

AT

On Market Since

3/31/2010

Pharmacological Classes

Decreased Sebaceous Gland Activity
Lincosamide Antibacterial
Lincosamides
Neuromuscular Blockade

Price Statistics

The NADAC for CLINDAMYCIN PHOSPHATE 1% FOAM has been published 434 times since Nov 28, 2013, and over the history we have for it it has declined 39.7%. The table below summarizes its recorded NADAC range and movement.

Current price$1.7318 per GM
All-time high$4.2831 (Dec 14, 2016)
All-time low$1.7318 (Nov 18, 2026)
52-week high$3.0421
52-week low$1.7318
Median price$3.6987
Average price$3.4191
Largest weekly change+17.8% (Feb 18, 2015)
Weeks tracked434
Tracking sinceNov 28, 2013

Price History

1W

-2.9%

1M

-5.4%

3M

-9.3%

6M

-24.9%

1Y

-43.1%

3Y

-53.2%

5Y

-53.2%

All

-39.7%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CLINDAMYCIN PHOSPHATE 1% FOAM?

The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN PHOSPHATE 1% FOAM, manufactured by Padagis Israel Pharmaceuticals Ltd, is $1.7318 per GM (NDC 45802066033), effective Nov 18, 2026.

How has the price of CLINDAMYCIN PHOSPHATE 1% FOAM changed over time?

Over the history we have for it, the NADAC for CLINDAMYCIN PHOSPHATE 1% FOAM has declined 39.7%. It has been tracked across 434 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CLINDAMYCIN PHOSPHATE 1% FOAM?

Since Nov 28, 2013, the NADAC for CLINDAMYCIN PHOSPHATE 1% FOAM has ranged from a low of $1.7318 (Nov 18, 2026) to a high of $4.2831 (Dec 14, 2016), with a median of $3.6987 per GM.

Are there cheaper alternatives to CLINDAMYCIN PHOSPHATE 1% FOAM?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CLINDAMYCIN PHOSPHATE 1% FOAM in a comparable dosage form, but none are currently priced below it.

Who manufactures CLINDAMYCIN PHOSPHATE 1% FOAM?

CLINDAMYCIN PHOSPHATE 1% FOAM (NDC 45802066033) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.